The website afm.nl uses cookies

Register price-sensitive press releases

In this register, you can find press releases (as of 1 October 2005) of issuing institutions that are admitted to trading in the Netherlands, as defined in art. 5:25i (1)(a) Wft. On the basis of Article 5:25i (2) of the Financial Supervision Act (Wft), these companies are obliged to publish price-sensitive information by means of, among other things, a press release. The AFM is required, on the basis of Article 1:107(3)(c) of the Wft at 2, to maintain a public register of these press releases.

This register will be updated several times a day. Press releases will be shown in the register with a slight delay after the publication. The register is meant to be used as an archive.

Publication date: 07 aug 2012 - 07:27
Statutory name: Koninklijke DSM N.V.
Title: DSM reports robust Q2 in challenging environment
Comments: - Q2 EBITDA from continuing operations €290 million (Q2 2011: €339 million) - Life Sciences continues to deliver robust performance, driven by Nutrition - Materials Sciences improved, except for caprolactam which had an EBITDA impact of - €70 million - Q2 cash flow from operating activities at €197 million, higher than comparable and prior quarter - Profit Improvement Program announced: expected annual EBITDA benefits of €150 million by 2014 - Interim dividend of €0.48 declared, in line with DSM's dividend policy - Outlook 2012 largely unchanged with the exception of caprolactam
Last update 24 mei 2013